Cidara Therapeutics Inc.
07/18/2024 | Press release | Distributed by Public on 07/18/2024 14:32
Submission of Matters to a Vote of Security Holders Form 8 K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 18, 2024, Cidara Therapeutics, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the stockholders of the Company approved the Company's 2024 Equity Incentive Plan (the "2024 EIP").
A detailed summary of the material features of the 2024 EIP, including the terms of stock option grants thereunder, is set forth in the Company's definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on June 3, 2024. That summary and the foregoing description are qualified in its entirety by the 2024 EIP, which is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.